Mounjaro®
Starting from £179.99/mo
Start journey Learn moreShivers, chills and a sudden feeling of cold are reported by some people taking Mounjaro (tirzepatide), most commonly in the hours after an injection. They are not listed as a primary side effect in the Mounjaro prescribing information, but they are consistent with the way tirzepatide changes how the body regulates temperature and metabolism. For the majority of people who notice them, the shivers pass within a day and settle as the body adjusts to treatment. That said, any new or persistent physical symptom on a prescription medicine warrants a conversation with your prescribing team. Mounjaro is a prescription-only medicine; a clinician assesses your full health picture before it is prescribed and supports you throughout treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Strictly speaking, "shivers" or "chills" do not appear by name in the Mounjaro Summary of Product Characteristics. What the SmPC does list includes fatigue, dizziness and a range of gastrointestinal symptoms — and the NHS patient guide to tirzepatide echoes this profile. So where do shivers fit in?
The reported experience sits at the intersection of two things. First, tirzepatide is a dual GIP and GLP-1 receptor agonist, and both pathways have roles in thermogenesis, the process by which the body generates heat from energy. Activating these receptors changes how efficiently your body burns fuel at rest, which can produce sensations of cold or warmth that feel unfamiliar, especially in the early weeks. Second, the nausea and reduced food intake that many people experience after starting or increasing Mounjaro means the body is taking in fewer calories for a short period. Less fuel, less heat production: that can translate to feeling cold or shivery even in a warm room.
Because neither mechanism is unique to tirzepatide, reports of chills appear across GLP-1 medicines generally, even though they are not formally tabulated in the same way that nausea or constipation are. That does not make them rare, and it does not make them something to dismiss. It means your prescriber needs the full picture to advise you properly. More about how tirzepatide works as a medicine is available if you want to read further into the mechanism.
Timing matters here. Most people who report shivering describe it appearing within a few hours of their weekly injection, peaking somewhere between two and six hours post-dose, then fading. This timing lines up with tirzepatide's initial absorption window, when plasma levels are rising most steeply.
The pattern also tends to be strongest at two specific points in treatment: the very first injections (when the body has no prior experience of the medicine) and each time the dose steps up. If you have just moved to a new strength and noticed chills you did not have before, that sequence is the most likely explanation. For most people the shivering softens or disappears entirely as they settle into the new dose over a few weeks.
One practical detail worth noting: some people find symptoms feel sharper if the pen has been taken straight from the fridge. Letting the pen sit at room temperature for 30 minutes before injecting can take the edge off the initial discomfort, though for the full guidance on preparation and storage you should follow your Patient Information Leaflet. If you are not sure what to expect at each stage of treatment, the Mounjaro preparation checklist covers the essentials.
For most people, brief chills after a Mounjaro injection are benign and self-limiting. There are, however, situations where shivering needs more than patient reassurance.
Rigors (the intense, uncontrollable shaking that accompanies high fever) are not a normal feature of Mounjaro treatment. If you are shivering with a fever above 38°C, feel genuinely unwell rather than just mildly cold, or have other symptoms such as chest tightness, a racing heart or severe stomach pain, those are reasons to seek medical help promptly rather than noting it in a diary for your next check-in.
The MHRA's January 2026 Drug Safety Update on GLP-1 medicines drew attention to acute pancreatitis as a serious but infrequent risk: the signal symptom is severe, persistent abdominal pain that may radiate to the back. Shivering alongside that pain pattern should be treated as an urgent medical matter. You can report any suspected side effect through the MHRA Yellow Card scheme, which is open to patients as well as clinicians.
Tirzepatide also carries a Black Triangle (▼) designation, meaning the MHRA continues to collect additional safety data on it. Reporting unusual symptoms is genuinely useful, it is how the post-market safety picture gets built. For a broader look at other physical reactions that sometimes arise on treatment, the page on whether Mounjaro can cause hives covers skin-related responses in detail, and if you have noticed raised, itchy welts specifically you can read more about Mounjaro hives and what tends to cause them.
Start by noting the specifics: which day of the week you injected, roughly when the shivering started, how long it lasted, and whether anything else was going on, a smaller meal than usual, a late injection time, or a recent dose increase. Patterns spotted in a simple note on your phone are far more useful to your prescriber than a vague recollection weeks later.
If the shivers are mild and short-lived, staying warm, keeping hydrated and resting for a few hours is usually sufficient. Dehydration can amplify that cold, fragile feeling, particularly if nausea has also reduced what you have been drinking. Sipping water steadily matters more than most people expect.
If the symptom is bothering you, your prescriber may consider whether the titration pace suits you, or whether any other factor is contributing. The free consultation at nume includes ongoing clinical support for exactly this kind of question, symptoms that are not dangerous but are affecting how you feel about your treatment. Reach out through our Mounjaro collection page if you need to speak with someone between scheduled reviews.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.